Log in with your email address username.


[Correspondence] Mainstreaming genomic medicine

The recent Editorial published in The Lancet (July 15, p 203)1 in response to the Generation Genome report argued that, because of current pressures in the National Health Service (NHS), coupled with insufficient evidence of clinical usefulness, now may not be the time for mainstreaming genomic medicine. I would like to suggest that there are inherent limitations to the transformative potential of genomics.